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Abstract
The development of classically activated monocytic cells (M1) is a prerequisite for effective elimination of parasites,
including African trypanosomes. However, persistent activation of M1 that produce pathogenic molecules such as TNF and
NO contributes to the development of trypanosome infection-associated tissue injury including liver cell necrosis in
experimental mouse models. Aiming to identify mechanisms involved in regulation of M1 activity, we have recently
documented that during Trypanosoma brucei infection, CD11b
+Ly6C
+CD11c
+ TNF and iNOS producing DCs (Tip-DCs)
represent the major pathogenic M1 liver subpopulation. By using gene expression analyses, KO mice and cytokine
neutralizing antibodies, we show here that the conversion of CD11b
+Ly6C
+ monocytic cells to pathogenic Tip-DCs in the
liver of T. brucei infected mice consists of a three-step process including (i) a CCR2-dependent but CCR5- and Mif-
independent step crucial for emigration of CD11b
+Ly6C
+ monocytic cells from the bone marrow but dispensable for their
blood to liver migration; (ii) a differentiation step of liver CD11b
+Ly6C
+ monocytic cells to immature inflammatory DCs
(CD11c
+ but CD80/CD86/MHC-II
low) which is IFN-c and MyD88 signaling independent; and (iii) a maturation step of
inflammatory DCs to functional (CD80/CD86/MHC-II
high) TNF and NO producing Tip-DCs which is IFN-c and MyD88 signaling
dependent. Moreover, IL-10 could limit CCR2-mediated egression of CD11b
+Ly6C
+ monocytic cells from the bone marrow
by limiting Ccl2 expression by liver monocytic cells, as well as their differentiation and maturation to Tip-DCs in the liver,
showing that IL-10 works at multiple levels to dampen Tip-DC mediated pathogenicity during T. brucei infection. A wide
spectrum of liver diseases associates with alteration of monocyte recruitment, phenotype or function, which could be
modulated by IL-10. Therefore, investigating the contribution of recruited monocytes to African trypanosome induced liver
injury could potentially identify new targets to treat hepatic inflammation in general, and during parasite infection in
particular.
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Introduction
Inflammatory immune responses against invading pathogens
require the recruitment of immune cells to the site of infection.
However, the infiltration of infected tissue by activated immune
cells may result in tissue injury justifying a profound understanding
of the mechanisms underlying the recruitment and activation of
inflammatory cells. Experimental infections with African trypano-
somes, extracellular blood-borne parasites that cause sleeping
sickness in humans and Nagana disease in cattle in sub-Saharan
Africa [1,2], are used as model systems to study infection-
associated liver pathogenicity [3]. In murine models, the control of
parasitemia is mostly mediated in the liver by IFN-c- and MyD88-
dependent generation of classically activated monocytic cells (M1)
that secrete trypanotoxic molecules TNF and NO and exert
phagocytic activity [4,5,6,7]. Within M1, CD11b
+Ly6C
+CD11c
+
inflammatory DCs have been identified as the main population
producing TNF and NO during Trypanosoma brucei infection [8].
These TNF and iNOS producing DCs (Tip-DCs) originated from
bone marrow CD11b
+Ly6C
+ monocytic cells recruited to the
liver, spleen and lymph nodes of infected mice. On the other hand,
the production of TNF and NO contributes to infection-associated
pathogenicity including liver cell apoptosis/necrosis, resulting in
organ failure and thus negatively affecting survival of the T. brucei
infected host [3]. In this respect, IL-10 was shown to limit liver
inflammation/injury and prolong survival by dampening the IFN-
c producing activity of T cells [9,10] and by directly limiting the
differentiation of CD11b
+Ly6C
+ monocytic cells to functional Tip-
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associated with alternative activation of monocytic cells (M2) that
could contribute to anti-inflammatory and wound-healing pro-
cesses during African trypanosome infection [10,11].
Since the recruitment of bone marrow derived CD11b
+Ly6C
+
monocytic cellsto inflamed tissue and their subsequent differentiation
in M1-type, TNF and NO producing CD11b
+Ly6C
+CD11c
+ Tip-
D C sm a yh a v ean e g a t i v ei m p a c to nt h eo u t c o m eo fT. brucei
infection, interfering with their recruitment to inflamed tissue could
lead to new anti-disease treatments. Therefore we scrutinized the
potential pathways governing the recruitment of inflammatory
CD11b
+Ly6C
+ monocytic cells to the liver as well as their subsequent
differentiation to functional Tip-DCs during T. brucei infection.
Results
Induction of chemokines in the liver of T. brucei infected
mice
T. brucei infection in C57Bl/6 mice is characterized by a
massive expansion of CD11b
+Ly6C
+ monocytic cells in the liver
[8]. These cells are closely related to CD11b
+Ly6C
+CCR2
+
inflammatory monocytes that are recruited in infected tissues
during microbial infection [12]. To identify pathway(s) possibly
involved in the recruitment of liver CD11b
+Ly6C
+ monocytic
cells, a custom in-house developed mRNA array was used to
screen for the expression of chemokine genes in total liver
extracts at day 6 post infection, i.e. when the first most important
peak of parasitemia and the highest expansion of CD11b
+Ly6C
+
monocytic cells in the liver (reaching 27.862.5% within liver
non-parenchymal cells in infected animals versus 2.160.3% in
non-infected mice) occur [8]. Seven chemokine genes were found
to be significantly induced (more than 2-fold as compared to
gene expression in total liver extracts from non-infected mice)
and their expression in total liver extracts was subsequently
confirmed by RT-PCR (Table 1). The identified genes included
(i) T cell-attracting chemokine genes; Cxcl10 (IP-10) and Cxcl9
(Mig) acting through the CXCR3 receptor and (ii) monocyte-
attracting chemokine genes; Ccl3 (MIP-1a), Ccl4 (MIP-1b)a n d
Ccl5 (RANTES), all ligands for the CCR5 chemokine receptor;
Ccl2 (MCP-1), the preferential ligand for chemokine receptor
CCR2; and Mif that interacts predominantly with the CD74
receptor but also potentially with CXCR2 and CXCR4. These
data raised the possibility that signaling through CCR5 or CCR2
chemokine receptor or through Mif may be involved in the
recruitment of liver associated CD11b
+Ly6C
+ monocytic cells
during T. brucei infection. This hypothesis was supported by the
observation that liver CD11b
+Ly6C
+ monocytic cells expressed
CCR2, CCR5 and CD74 on their surface, although at different
levels (Fig. 1A).
Signaling through CCR2, but not CCR5 or Mif, is required
for bone marrow to blood egression of CD11b
+Ly6C
+
monocytic cells during T. brucei infection
To evaluate whether CCR2, CCR5 or Mif signaling plays a
role in the recruitment of CD11b
+Ly6C
+ monocytic cells to the
liver, CCR2 KO, CCR5 KO, Mif KO mice and their respective
WT counterparts were infected with T. brucei. In CCR5 KO and
Mif KO mice, no difference in the percentage of liver, blood or
bone marrow CD11b
+Ly6C
+ monocytic cells was observed
compared to WT mice on day 6 of T. brucei infection
(Figure 1B). In infected CCR2 KO mice, the percentage of
CD11b
+Ly6C
+ monocytic cells was drastically reduced (.75%)
as compared to infected WT mice in both the liver and the blood,
and coincided with an increase of the percentage of
CD11b
+Ly6C
+ monocytic cells in the bone marrow (Figure 1B,
1C). Similar modulations were observed for absolute numbers of
CD11b
+Ly6C
+ monocytic cells in the liver, blood and bone
marrow of the respective mouse strains during infection
(Figure 1D). These data suggest that the recruitment of
CD11b
+Ly6C
+ monocytic cells to the liver of T. brucei infected
mice consists of a two-step process comprising a CCR2-
dependent, yet CCR5- and Mif-independent egression step from
bone marrow to blood, followed by an extravasation step from
blood to liver. Since in CCR2 KO mice CD11b
+Ly6C
+
monocytic cells accumulated in the bone marrow, it was unclear
whether CCR2 also played a role in blood to liver extravasation
during infection. To address this question, CD11b
+Ly6C
+
Author Summary
Most infections are associated with host inflammatory
responses that can result in multiple organ failure and
death. It is therefore essential to understand the mecha-
nisms balancing host immune response and tissue
damage. Mouse models of African trypanosome infection
represent valuable tools to study the mechanisms
contributing to the inflammatory (pathogenic) or anti-
inflammatory (anti-pathogenic) immune response. We
recently identified TNF and NO producing DCs (Tip-DCs)
as major contributors to liver pathogenicity in Trypanoso-
ma brucei infected mice. Herein, the role of different
chemokine and cytokines in the generation of Tip-DCs was
investigated. Tip-DCs originated from bone marrow
derived monocytes that egressed to the blood in a CCR2
chemokine receptor dependent manner. Then, monocytes
extravasated to inflamed liver where IFN-c and MyD88
signaling promoted their maturation to Tip-DCs. Both the
egression of monocytes from bone marrow and their IFN-
c/MyD88 dependent maturation to Tip-DCs was counter-
acted by IL-10, hereby reducing liver pathogenicity. Liver
injury, affecting millions of persons worldwide with often
lethal consequences, frequently results from uncontrolled
activation of recruited monocyte-derived cells that can be
modulated by IL-10. Thus, the mechanisms regulating liver
immunopathogenicity during parasitic infection identified
herein could lead to new therapeutic policies in the field of
hepatic inflammation.
Table 1. Chemokine mRNA expression levels in total liver
extracts from T. brucei infected mice as determined by
real-time PCR.
Chemokine Fold induction
a Receptor(s)
Cxcl9 (MIG) 4.460.8 CXCR3
Cxcl10 (IP-10) 9.761.2 CXCR3
Ccl3 (MIP-1a)4 . 5 60.6 CCR5, CCR1
Ccl4 (MIP-1b) 10.561.7 CCR5
Ccl5 (RANTES) 5.660.8 CCR5, CCR1, CCR3
Ccl2 (MCP-1) 5.360.9 CCR2
Mif 11.261.3 CD74, CXCR2, CXCR4
aon day 6 post infection, normalized with the ribosomal protein S12 gene and
expressed relative to liver extract from non-infected mice. Data are shown as
mean 6 SEM of three individual mice of one of two independent experiments.
p,0.05 for all values compared to non-infected mice.
doi:10.1371/journal.ppat.1001045.t001
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infected WT and CCR2 KO mice, labeled (using PKH26 and
CellVue labeling kits respectively), and co-injected at a 1-1 ratio
in infected WT recipient mice. Twenty four hours later, liver
non-parenchymal cells from recipient mice were analyzed for the
presence of labeled cells. As shown in figure 2, the 1-1 ratio of
transferred WT to CCR2 KO CD11b
+Ly6C
+ monocytic cells
could be traced back in infected WT recipient mice, demon-
strating that the absence of CCR2 signaling in monocytic cells
had no effect on blood to liver migration of CD11b
+Ly6C
+
monocytic cells during T. brucei infection. To verify whether
expression of CCR2 by cells other than CD11b
+Ly6C
+
monocytic cells affected the recruitment of the latter cells from
the blood to the liver, CD11b
+Ly6C
+ monocytic cells isolated
from the bone marrow of T. brucei infected WT mice and labeled
with PKH26 were transferred into infected CCR2 KO or WT
recipient mice. The percentage of transferred CD11b
+Ly6C
+
cells found back in the liver after 24 hours was not significantly
different between CCR2 KO or WT recipients (0.460.2% or
0.360.1%, respectively). Thus, these data indicate that the
CCR2 chemokine receptor signaling in CD11b
+Ly6C
+ mono-
cytic cells is crucial for their bone marrow emigration but
dispensable for their blood to liver extravasation during T. brucei
infection.
Figure 1. CD11b
+Ly6C
+ monocytic cells are affected by CCR2 but not CCR5 or Mif signaling during T. brucei infection. A) Inflammatory
monocytic cells gated based on their expression of CD11b and Ly6C from non-parenchymal cells isolated from the liver of WT mice on day 6 of T.
brucei infection were stained for CCR2, CCR5 or CD74 expression (filled grey curves compared to dotted line curves representing specific isotype
controls) FACS profiles are representative of one of four animals tested in two independent experiments. B) Percentage and D) Number of
CD11b
+Ly6C
+ monocytic cells in liver non-parenchymal, blood and bone marrow of CCR2 KO, CCR5 KO and Mif KO mice on day 6 post infection. Data
are shown as mean 6 SEM of three individual mice of one of three independent experiments performed. C) Non-parenchymal cells isolated from
liver, blood and bone marrow of WT and CCR2 KO mice on day 6 post infection were assayed for co-expression of CD11b and Ly6C. Percentages of
CD11b
+Ly6C
+ monocytic cells within the indicated gate are shown. FACS profiles are representative of one of nine animals tested in three
independent experiments. *, significantly lower (p,0.01) and **, significantly higher (p,0.05) compared to WT mice.
doi:10.1371/journal.ppat.1001045.g001
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and pathogenicity during T. brucei infection
During T. brucei infection, up to 70% of the CD11b
+Ly6C
+
liver monocytic cells can co-express CD11c, classifying them as
inflammatory CD11b
+Ly6C
+CD11c
+ dendritic cells [8]. The
percentage of CD11c
+ cells within the CD11b
+Ly6C
+ mono-
cytic cell population in the liver of T. brucei infected mice was
not affected by the absence of CCR2 (Figure 3). Also, the
percentage of TNF
+ and iNOS
+ cells within CD11b
+Ly6C
+
monocytic cells (Figure 3) and their expression levels of co-
stimulatory molecules CD80/CD86 and MHC class II (not
shown) was similar in WT and CCR2 KO mice, indicating that
CCR2 signaling is not involved in the differentiation of
CD11b
+Ly6C
+ monocytic cells to functional Tip-DCs during
T. brucei infection. However, in agreement with the reduced
percentage of CD11b
+Ly6C
+ monocytic cells in the liver of
CCR2 KO mice (Figure 1), we observed a significantly reduced
percentage of TNF
+ and iNOS
+ Tip-DCs within the total liver
non-parenchymal cell population of CCR2 KO mice compared
to WT mice (Figure 3). The reduced percentage of Tip-DCs in
the liver of infected CCR2 KO mice associated with (i) a
significant reduction of TNF, NO and IFN-c secretion in liver
non-parenchymal cell cultures and ii) a reduced percentage of
liver IFN-c
+CD4
+ and IFN-c
+CD8
+ Tc e l l sc o m p a r e dt o
infected WT mice (Figure 4).
Although TNF and IFN-c are involved in the control of
parasitemia during T. brucei infection [4,13], parasitemia in WT
and CCR2 KO mice was similar indicating that reduced
production of TNF and IFN-c in CCR2 KO mice was still
sufficient for efficient parasite control (not shown). On the other
hand, the expansion of Tip-DCs and their concomitant produc-
tion of TNF and NO may contribute to liver injury and reduced
survival of T. brucei infected mice [8]. In this context, infected
CCR2 KO mice exhibited lower levels of serum ALT than
infected WT mice on day 28 post infection (Figure 5A), i.e. when
the lethal pathogenic features of the disease become apparent.
Reduced liver injury in T. brucei infected CCR2 KO mice was
further confirmed by histological analysis (Figure 5B). Finally,
decreased liver injury in the absence of CCR2 signaling correlated
with a significantly increased survival time (from 3263 days in
WT mice to 5364 days in CCR2 KO mice) (Figure 5C). Thus, in
the absence of CCR2 signaling, the reduction in the percentage of
CD11b
+Ly6C
+ monocytic cells and concomitant reduction in Tip-
DC percentage in T. brucei infected mice lowers the production of
TNF and NO in the liver, reduces liver injury while preserving
parasite clearing capacity and increases the survival time of the
host.
To further support a role for Tip-DCs in pathogenicity during
T. brucei infection, we transferred their CD11b
+Ly6C
+ monocytic
cell precursors purified from the bone marrow of WT infected
mice into infected recipient CCR2 KO mice on day 6 post
infection. Twenty four hours after transfer a significantly
increased concentration of TNF and increased ALT activity in
blood serum of recipient CCR2 KO mice was observed (Figure 6).
In contrast, transfer of CD11b
+Ly6C
+ monocytic cell purified
from TNF KO mice affected neither TNF nor ALT levels of
recipient CCR2 KO mice (Figure 6). Although up to 5264% of
WT CD11b
+Ly6C
+ monocytic cells co-expressed CD11c and
MHC-II after transfer, reflecting their differentiation and
maturation towards Tip-DCs, TNF and ALT levels in recipient
CCR2 KO mice did not reach levels achieved in infected WT
mice at the same time point post infection (Figure 6). This may
result from the low percentage of transferred cells recovered in
the liver (0.960.1% of the non-parenchymal cell fraction
corresponding to about 1.260.2610
5 cells), which is likely due
to the systemic nature of T. brucei infection [14]. These data
strongly suggest that Tip-DCs contribute to pathogenicity during
T. brucei infection.
IL-10 limits CCL2/CCR2 mediated recruitment of
CD11b
+Ly6C
+ monocytic cells during T. brucei infection
IL-10 has been shown to limit the generation of Tip-DCs from
CD11b
+Ly6C
+ cells during T. brucei infection [8]. In agreement,
treatment with neutralizing anti-IL-10R antibody on days 7 and 9
post infection, i.e. at the peak of IL-10 production [8] increased
the differentiation of CD11b
+Ly6C
+ monocytic cells towards
inflammatory DCs and their subsequent maturation to Tip-DCs in
the liver (Figure 3). At this point, it was not established whether IL-
10 also directly influenced the recruitment of liver associated
CD11b
+Ly6C
+ monocytic cells. To consider this possibility, WT
and CCR2 KO T. brucei infected mice were treated with
neutralizing anti-IL-10R antibody. In WT but not in CCR2 KO
Figure 2. CCR2 does not contribute to liver extravasation of CD11b
+Ly6C
+ monocytic cells during T. brucei infection. WT and CCR2 KO
CD11b
+Ly6C
+ monocytic cells were isolated from bone marrow of mice on day 6 of infection, labeled with PKH26 and CellVue kits, respectively, and
injected at a 1-1 ratio in the blood of recipient WT mice on day 6 of T. brucei infection. Left panel shows percentages of gated, labeled WT and CCR2
KO cells before injection. 24 hours after transfer liver non-parenchymal were harvested from recipient mice and analysed for the presence of labeled
cells. Percentages of gated, labeled WT and CCR2 KO cells are shown (right panel). FACS profiles are representative of one of six animals tested in two
independent experiments.
doi:10.1371/journal.ppat.1001045.g002
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KO mice [8], killing the mice at 1161 days post infection with
increased liver injury (serum ALT levels: 810668 versus
223639 U/ml in anti-IL-10R and control antibody treated WT
mice at day 10 post infection). In the liver as well as in the blood of
infected anti-IL-10R antibody treated WT mice the percentage of
CD11b
+Ly6C
+ monocytic cells within total liver non-parenchymal
cells doubled compared to infected control antibody treated WT
mice (Figure 7). In contrast, the percentage of liver and blood
CD11b
+Ly6C
+ monocytic cells did not change in CCR2 KO mice
upon anti-IL-10R antibody treatment, showing that IL-10
regulates peripheral CD11b
+Ly6C
+ monocyte percentages in a
CCR2-dependent way. Of note, the percentage of bone marrow
CD11b
+Ly6C
+ monocytic cells did not change in anti-IL-10R
treated WT or CCR2 KO mice, suggesting that IL-10 signaling
did not alter bone marrow monopoiesis (Figure 7). Interestingly,
gene expression level of the main CCR2 ligand Ccl2 (fold
induction compared to non infected mice) was further induced in
total liver extracts upon anti-IL-10R antibody treatment in
infected WT mice (from 5.360.9 in control antibody treated
mice to 16.461.4 in anti-IL-10R antibody treated mice, p,0.05).
In addition, blood serum levels of CCL2 increased upon anti-IL-
10R treatment (Figure 7). These data indicate that IL-10 limits
CD11b
+Ly6C
+ monocyte cell recruitment to the liver and the
blood during T. brucei infection in a CCR2-dependent manner,
likely by limiting the production of CCL2.
IFN-c and MyD88 signaling induce the generation of Tip-
DCs from CD11b
+Ly6C
+ monocytic cells during T. brucei
infection
While the generation of Tip-DCs from liver associated
CD11b
+Ly6C
+ monocytic cells in T. brucei infected mice was
impaired by IL-10, the mechanisms triggering this generation are
undefined. In this regard, although IFN-c and MyD88 signaling
were documented to contribute to TNF and NO production in T.
brucei infected mice [5,15], it is unknown whether IFN-c and/or
MyD88 signaling are involved in Tip-DC differentiation during
infection. As shown in Figure 3A, the percentage of CD11c
+
inflammatory DCs within the liver CD11b
+Ly6C
+ population was
not affected in the absence of IFN-c or MyD88 signaling during T.
brucei infection. However, infected IFN-c KO and MyD88 KO
mice had significantly lower percentages of TNF and iNOS
producing cells within the CD11b
+Ly6C
+CD11c
+ inflammatory
DCs (Figure 3A). Also, expression levels of co-stimulatory
molecules CD80/CD86 and MHC class II were reduced in liver
inflammatory DCs from IFN-c or MyD88 KO compared to WT
mice (not shown). To further determine the role of MyD88 and
Figure 3. CCR2, IL-10R, MyD88 and IFN-c signaling differentially contribute to Tip-DC differentiation/maturation during T. brucei
infection. A) Liver non-parenchymal cells were isolated from WT, CCR2 KO, anti-IL-10R treated WT, MyD88 KO and IFN-c KO mice on day 6 of infection.
CD11b
+Ly6C
+monocyticcellsweregated(asindicatedinfigure1C)andassayedforco-expressionofCD11bandCD11c(toppanels),TNF(middlepanels)or
iNOS (bottom panels). Percentages of CD11c
+,T N F
+ or iNOS
+ cells (rectangular gate) within CD11b
+Ly6C
+ monocytic cells are indicated. Corresponding
percentages of CD11c
+,T N F
+ or iNOS
+ cells within the total number of living non-parenchymal cells recovered from the liver are indicated between
brackets. Data are shownas mean 6 SEMof three individual miceof one of three independent experiments performed. FACS profiles are representative of
one of nine animals tested in three independent experiments performed. B) CD11b
+Ly6C
+ monocytic cells were isolated from bone marrow of WT and
MyD88 KO or IFN-cRK Om i c eo nd a y6o fT. brucei infection, labeled with PKH26 (WT) and CellVue kits (KO), and injected at a 1-1 ratio in the blood of
recipient WT mice on day 6 of T. brucei infection. Twenty four hours after transfer, liver non-parenchymal were harvested from recipient mice and analyzed
for the presence of labeled cells. Percentages of gated, labeled WT and MyD88 or IFN-cR KO cells after transfer are shown (left panels). The expression of
MHC-II molecules on the gated labeled cells is shown in the right panels. Data are shown as mean 6 SEM of three individual mice of one of three
independent experimentsperformed.FACS profiles are representativeofone of four animals tested in threeindependentexperiments.Notethat due tot he
low numbers of transferred cells recovered from the liver, we were unable to assess iNOS or TNF expression on transferred cells using intracellular staining
assays. *, significantly lower (p,0.05) and **, significantly higher (p,0.05) compared to WT mice.
doi:10.1371/journal.ppat.1001045.g003
Figure 4. Absence of CCR2 signaling reduces TNF, NO and IFN-c production during T. brucei infection. At day 6 post infection, A)
production of TNF, NO2 (as measure of NO) and IFN-c by unstimulated liver non-parenchymal cells after 24 hours of in vitro culture and B)
percentages of CD4
+IFN-c
+ and CD8
+IFN-c
+ cells within the liver non-parenchymal cell fraction were determined in WT (white bars) and CCR2 KO
(grey bars) mice. Data are shown as mean 6 SEM of three individual mice of one of three independent experiments performed. *, significantly
(p,0.05) lower compared to WT mice.
doi:10.1371/journal.ppat.1001045.g004
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1-1 ratio CD11b
+Ly6C
+ monocytes isolated from the bone
marrow of T. brucei infected WT and MyD88 KO on the one
hand, and from infected WT and IFN-cR KO on the other hand,
in infected WT recipient mice. Twenty four hours later, the 1-1
ratio of WT versus KO transferred cells was maintained in the
liver (Figure 3B), suggesting that IFN-cR or MyD88 signaling was
not involved in blood to liver extravasation. In addition, (i) similar
percentages of transferred CD11b
+Ly6C
+ monocytic cells from
WT, IFN-cR KO and MyD88 KO expressed CD11c (5463%,
5264% and 5064% respectively) and (ii) the expression of MHC-
II (Figure 3B) and CD80/CD86 (not shown) molecules was
significantly reduced on transferred IFN-cR KO and MyD88 KO
CD11b
+Ly6C
+ monocytic cells compared to WT, confirming our
findings in T. brucei infected IFN-c KO and MyD88 KO mice that
maturation of CD11c
+CD11b
+Ly6C
+ inflammatory DCs towards
a mature Tip-DC phenotype is dependent on both IFN-c and
MyD88 signaling.
Together, these data indicate that IFN-c and MyD88 signaling
are not required for the differentiation of CD11b
+Ly6C
+
monocytic cells towards CD11b
+Ly6C
+CD11c
+ inflammatory
DCs, but play a role in their further maturation to functional
Tip-DCs by inducing the expression of iNOS, TNF and
costimulatory molecules.
Discussion
Murine monocytic cells comprise of distinct functional subsets
that can be distinguished based on their expression of the surface
markers CD11b, Ly6C, CX3CR1 and CCR2 [16]. One subset
consists of CD11b
+CX3CR1
lowCCR2
highLy6C
high ‘‘inflammatory
monocytes’’, referred to here as CD11b
+Ly6C
+ monocytic cells,
Figure 6. Transfer of CD11b
+Ly6C
+ TIP-DC precursors increases pathogenicity during T. brucei infection. CD11b
+Ly6C
+ monocytic cells
were isolated from the bone marrow of WT or TNF KO mice on day 6 of T. brucei infection, labeled with CellVue and transferred intravenously into
infected recipient CCR2 KO mice. Twenty four hours after transfer blood serum was analyzed for TNF concentration and ALT activity. Data are mean 6
SEM of three individual mice of one of three independent experiments performed. Note that due to the low numbers of transferred cells recovered
from the liver, we were unable to assess iNOS or TNF expression on transferred cells using intracellular staining assays. *, significantly higher (p,0.05)
compared to CCR2 KO mice that did not receive CD11b
+Ly6C
+ monocytic cells.
doi:10.1371/journal.ppat.1001045.g006
Figure 5. Absence of CCR2 signaling reduces liver pathogenicity and prolongs survival of T. brucei infected mice. A) Serum ALT levels
were measured in WT and CCR2 KO mice on day 28 of infection (mean 6 SEM of three individual mice of one of two independent experiments
performed). *, significantly (p,0.05) lower compared to WT mice. B) Survival time of infected WT and CCR2 KO mice. Data are representative of one of
two independent experiments performed. *, significantly longer (p,0.05) compared to WT mice. C) Microscopic examination (H&E staining;
magnification 6100) of liver sections from WT and CCR2 KO mice on day 28 of infection (representative of 3 animals tested). In CCR2 KO mice
hepatocyte necrosis is low, whereas in WT mice important hepatitis and fields of necrosis are observed (arrows).
doi:10.1371/journal.ppat.1001045.g005
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infection [12]. There, inflammatory or pathogen-derived mole-
cules can induce activation of CD11b
+Ly6C
+ monocytic cells to
CD11c, CD80/86, MHC class II molecule expressing, TNF and
iNOS-producing DCs (Tip-DCs) [17]. Tip-DC activity can be
beneficial to the host by controlling growth of Listeria, Brucella,
Leishmania or influenza virus pathogens [17,18,19,20], however it
may also be pro-pathogenic by contributing to tissue damage such
as during infection with influenza virus or the African trypano-
some Trypanosoma brucei [8,20]. Herein, we have attempted to
unravel the pathways underlying the recruitment of
CD11b
+Ly6C
+ monocytic cells to the liver of T. brucei infected
mice and the factors regulating their differentiation to Tip-DCs
allowing a better understanding of the mechanisms underlying
African trypanosomiasis-associated pathogenicity.
Screening of total liver extracts for genes with upregulated
expression in T. brucei infection yielded chemokine genes
previously implicated in monocyte trafficking: Ccl2 (signaling
through CCR2), Ccl3-4-5 (signaling through CCR5) and Mif
(signaling through CD74, CXCR2, CXCR4) [21,22,23,24,25].
FACS analyses revealed that liver CD11b
+Ly6C
+ monocytic cells
from infected mice expressed high level of CCR2, low level of
CCR5 and CD74, and marginal level of CXCR2 and CXCR4
(not shown). No difference in the percentage of CD11b
+Ly6C
+
monocytic cells was observed in the bone marrow, blood and liver
of infected CCR5 KO or Mif KO mice. In contrast, percentages
of CD11b
+Ly6C
+ monocytic cells drastically dropped in liver and
blood while increasing in bone marrow of infected CCR2 KO
mice. Transfer experiments revealed that neither CCR2, nor
CCR5 or Mif (not shown) contributed to extravasation of bone
marrow-derived CD11b
+Ly6C
+ monocytic cells from blood to
liver of T. brucei infected mice. Together, these data show that
CD11b
+Ly6C
+ monocyte recruitment to the liver of T. brucei
parasite infected mice involved an egression step from the bone
marrow that is CCR2-dependent, followed by a CCR2-indepen-
dent extravasation step triggered by yet unidentified factors
released by the inflamed tissue, as documented during bacterial
infection [22,26].
CD11b
+Ly6C
+ monocytic cells entering the liver of T. brucei
infected mice first differentiate to CD11b
+Ly6C
+CD11c
+ inflam-
matory DCs and subsequently maturate to CD80/CD86 high,
MHC-II high, TNF and NO secreting Tip-DCs. Both this
differentiation and maturation step can be limited by IL-10 [8].
In addition, we show here that treatment of T. brucei infected mice
with anti-IL-10R antibody strikingly increased the percentage of
CD11b
+Ly6C
+ monocytic cells in blood and liver but not in the
bone marrow, excluding a role for IL-10 on the differentiation of
the inflammatory monocyte progenitor (the so-called macrophage
and DC precursor, MDP) [27,28]. However, increased percentage
of peripheral CD11b
+Ly6C
+ monocytic cells was not observed in
CCR2 KO mice treated with anti-IL-10R antibody. In addition,
CCL2 protein levels in the blood and gene expression of Ccl2 in
total liver extracts of infected mice was increased by anti-IL-10R
treatment during infection. Although many cell types can produce
CCL2, we found that Ccl2 gene expression was induced in liver
CD11b
+Ly6C
+ monocytic cells during infection and further
upregulated upon IL-10 neutralization, suggesting that IL-10
negatively regulates a CCL2 dependent positive feedback loop for
liver CD11b
+LyC6
+ monocyte recruitment. CD11c
2 and CD11c
+
CD11b
+Ly6C
+ monocytic cells contributed equally to the induced
expression of Ccl2 (not shown). Finally, the percentage of
CD11b
+Ly6C
+ monocytic cells was found increased in liver and
blood of IL-10 KO mice (not shown), further supporting a role for
IL-10 in regulating peripheral CD11b
+Ly6C
+ monocytic cell
numbers. Taken together, these data suggest that besides
impairing differentiation and maturation of CD11b
+Ly6C
+
monocytic cells to Tip-DCs, IL-10 can counteract the CCL2/
CCR2-mediated recruitment of CD11b
+Ly6C
+ monocytic cells/
Tip-DCs to liver and blood of T. brucei infected mice.
MyD88 and IFN-c signaling have been implicated in the
generation of Tip-DCs in infection models including Leishmania,
Brucella and Listeria [18,19,29]. Knowing that during T. brucei
infection, the production of TNF and NO is impaired in MyD88
KO [5] and IFN-c KO mice (unpublished observation), we
investigated whether MyD88 or IFN-c signaling affected the
differentiation/maturation of CD11b
+Ly6C
+ monocytic cells to
Figure 7. Anti-IL-10R treatment increases CD11b
+Ly6C
+ monocytic cell percentages and serum CCL2 concentration during T. brucei
infection. WT mice were treated with neutralizing anti-IL-10R antibody or control antibody on days 7 and 9 of infection and euthanized on day 10. A)
Percentages of CD11b
+Ly6C
+ monocytic cells in the non-parenchymal liver cell fraction, blood and bone marrow of WT (white bars) and CCR2 KO
(grey bars) mice with or without anti-IL-10R treatment. B) CCL2 protein concentration in blood sera of WT T. brucei infected mice. Data are the mean
6 SEM of three individual mice tested in one of three independent experiments performed. *, significantly (p,0.05) higher compared to control
treated WT mice.
doi:10.1371/journal.ppat.1001045.g007
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percentage of liver associated CD11b
+Ly6C
+ monocytic cells, their
extravasation and their differentiation to inflammatory DCs was
unaffected by the absence of MyD88 or IFN-c signaling. On the
other hand, inflammatory DCs from infected MyD88 KO mice
and IFN-c KO mice expressed lower levels of CD80/86, MHC
class II molecules and produced less TNF and iNOS protein,
indicating that MyD88 and IFN-c signaling are involved in the
maturation of inflammatory DCs to functional Tip-DCs. The
currently identified T. brucei-derived MyD88 signaling triggers, the
glycosylphosphatidylinositol-anchored VSG and DNA, inducing
the production of TNF and NO, and endotoxin/LPS-like
substances from the trypanosome could represent candidates
contributing to Tip-DC maturation. While trypanosome DNA has
been suggested to interact with TLR9, TLRs that could interact
with other trypanosome derived molecules have not been
identified. Moreover, it cannot be excluded that increased LPS
release into the blood circulation due to secondary bacterial
infection and/or increased gut permeability contributes to TLR4-
dependent Tip-DC maturation during trypanosome infection
[5,30,31,32].
The function of DCs has been poorly examined in the context
of African trypanosome infection with the exception of the work
from Dagenais et al. showing that splenic conventional
CD11c
highCD8
+ and CD11c
highCD8
2 DCs during T. brucei
(rhodesiense) infection contribute to activation of VSG-specific
Th1 cell responses through the coordinated upregulation of
costimulatory molecules, secretion of IL-12, and presentation of
VSG peptides to T cells [33]. Conventional DCs in contrast to
Tip-DCs are believed not to derive from monocytes [34].
However, Tip-DCs can exhibit T-cell stimulatory capacity
[19,20]. In agreement, in the liver of T. brucei infected CCR2
KO mice, reduced percentage of Tip-DCs associated with reduced
percentage of IFN-c producing T cells, referred to previously as
‘‘pathogenic’’ T cells during African trypanosome infection [35].
Our observation that IFN-c signaling is necessary for the
generation of mature functional Tip-DCs in infected mice
supports a positive cross-regulation between T cells and Tip-
DCs mediated by IFN-c as was suggested during Leishmania
infection [19]. In addition to their immunostimulatory function,
Tip-DCs may contribute to parasite control during T. brucei
infection by producing TNF that is essential for this process [4].
Accordingly, T. brucei infected MyD88 KO mice and IFN-c KO
mice exhibited reduced Tip-DC percentage and reduced produc-
tion of TNF, correlating with an inability to efficiently control
parasitemia [5]. However, although Tip-DCs and TNF levels were
reduced in CCR2 KO mice, control of parasitemia was
unaffected. In this respect, it cannot be omitted that the present
work only focused on the role of liver associated CD11b
+Ly6C
+
monocytic cells while the role of resident liver monocytic cells,
including CD11b
2Ly6C
+ monocytic cells and CD11b
+ liver
Kupffer cells, remains to be addressed. While absence of CCR2
could only affect recruited CD11b
+Ly6C
+ monocytic cells,
absence of IFN-c and MyD88 signaling can impair the activation
of both recruited and resident liver monocytic cells during
infection. Moreover, the relative contribution of recruited versus
resident liver monocytic cells to parasite control and induction of
pathogenicity may differ. Indeed, .75% of T. brucei are removed
from circulation by resident liver Kupffer cells arguing for a major
role of these cells in parasite control [36]. On the other hand, a
more pro-pathogenic function for recruited CD11b
+Ly6C
+
monocytic cells/Tip-DCs is supported by the observation that in
CCR2 KO mice (this study) or in T. brucei infected mice treated
with IL-10 [8], reduced percentage of recruited CD11b
+Ly6C
+
monocytic cells/Tip-DCs associated with reduced pathogenicity
and increased survival without affecting parasitemia. In the same
vein, drastic shortened survival time of T. brucei infected IL-10 KO
mice due to excessive tissue injury coincided with increased levels
of CD11b
+Ly6C
+ monocytic cells/Tip-DC in the liver but normal
parasite clearance capacity [8,37]. Finally, our observation that
the transfer of CD11b
+Ly6C
+ monocytic cells from infected WT
mice that can maturate to Tip-DCs [8], but not from TNF KO
mice, increased TNF concentration and ALT activity in serum of
infected CCR2 KO recipients supports a role for these cells in the
induction of liver injury during T. brucei infection.
In conclusion, we have unraveled the pathways involved in the
recruitment of a major pathogenic Tip-DC population in the liver
of T. brucei infected mice (Figure 8). The development of Tip-DCs
is a multi-step process including (i) a CCR2-dependent egression of
CD11b
+Ly6C
+ inflammatory monocytic cells from bone marrow,
followed by (ii) a differentiation step to immature inflammatory
DCs (CD11c
+ but CD80/CD86/MHC-II
low) which is IFN-c and
MyD88 signaling independent and (iii) a maturation step of
inflammatory DCs to functional (CD80/CD86/MHC-II
high) TNF
and NO producing Tip-DCs which is IFN-c and MyD88 signaling
dependent. IL-10 could inhibit the CCL2/CCR2-mediated
egression of CD11b
+Ly6C
+ monocytic cells from the bone marrow
as well as their differentiation and maturation to Tip-DCs in the
liver. Liver injury in various etiologies can result from uncontrolled
activation of monocyte-derived cells recruited to the liver via
CCR2 signaling and can be modulated by IL-10 [38,39,40,41,42].
African trypanosome infections thus represent a useful model to
Figure 8. Model for migration, differentiation and maturation of CD11b
+Ly6C
+ monocytes to Tip-DCs during T. brucei infection.
doi:10.1371/journal.ppat.1001045.g008
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tools, including monocyte associated, IL-10 inducible genes we
have previously identified [10,11], to treat hepatic inflammation.
Materials and Methods
Ethics statement
The experiments, maintenance and care of mice complied with
the guidelines of the European Convention for the Protection of
Vertebrate Animals used for Experimental and other Scientific
Purposes (CETS nu 123). The experiments for this study were
approved by the Ethical Committee for Animal Experiments of
the Vrije Universiteit Brussel, VUB, Brussel, Belgium.
Parasites, mice and infections
Trypanosoma brucei AnTat 1.1E parasites were a kind gift from N.
Van Meirvenne (Institute for Tropical Medicine, Belgium).
Female mice kept under filter barrier were used at 8–12 weeks
of age. Wild type C57BL/6 mice were from Harlan, The
Netherlands. CCR2 KO, CCR5 KO and Mif KO C57BL/6
mice were kindly provided by Dr. D. Engel, University Clinic of
Bonn, Germany, Dr. F. Tacke, RWTH-University Hospital
Aachen, Germany and Prof. R. Bucala, Yale University School
of Medicine, New Haven, USA). IFN-c KO, TNF KO and
MyD88 KO C57BL/6 mice were bred in our animal facility.
Parasites stored at 280uC were used to infect cyclophosphamide
treated F1 (C57BL/66 BALB/c) mice bred in-house by i.p.
inoculation. At day 4 post infection, mice were bled, and parasites
were purified by diethyl-aminoethyl-cellulose chromatography.
C57BL/6 mice were then infected i.p. with 2000 purified
parasites. Parasitemia was monitored by tail blood puncture.
When required, mice were injected i.v. with 100 ml of a 1 mg/ml
PBS solution of anti-IL-10R antibody (1B1.3a, kindly provided by
Dr. M. Moser and C. Coquerelle, ULB, Gosselies, Belgium with
the agreement of Schering-Plough Biopharma) or control antibody
(rat IgG1, BD Biosciences) on days 7 and 9 of infection and
sacrificed on day 10.
Isolation of liver, blood and bone marrow immune cells
Liver non-parenchymal cells were isolated as follows. Animals
were euthanized (CO2) and livers were perfused through the
portal vein with 10 ml of 100 U/ml collagenase type III
(Worthington Biochemical Corporation) in HBSS. Then, the liver
was minced and incubated in 10 ml of a 100 U/ml collagenase III
solution in HBSS (20 min, 37uC). The resulting cell suspension
was passed through a 70 mm nylon mesh filter and then washed by
adding 30 ml of HBSS supplemented with 2 mM EDTA and 10%
FCS followed by centrifugation (300 g, 10 min, 4uC). After
erythrocyte lysis, pellet was resuspended in 10 ml of Lymphoprep
(Lucron Bioproducts) and overlayed with 10 ml of HBSS
supplemented with 2 mM EDTA and 10% FCS. After centrifu-
gation (430 g, 30 min, 17uC), the layer of low-density cells at the
interface containing non-parenchymal cells was harvested.
CD11b
+Ly6C
+Ly6G
+ liver granulocytes were not retained within
the non-parenchymal fractions due to their high density
characteristic. Bone marrow cells were isolated from hind leg
bone of CO2 euthanized animals by perfusion with 20 ml of HBSS
supplemented with 10% FCS (HBSS/FCS). The resulting cell
suspension was passed through a 100 mm nylon mesh filter,
centrifuged (300 g, 10 min, 4uC) and resuspended in HBSS/FCS.
Blood was isolated on EDTA by heart puncture of euthanized
mice, followed by thorough erythrocyte lysis, centrifugation
(300 g, 10 min, 4uC) and resuspension of blood immune cells in
HBSS/FCS. Immune cells and used buffers were kept on ice
during isolation protocols and subsequent analysis.
Transfer of monocytes
CD11b
+Ly6C
+ monocytes were isolated from the bone marrow
of infected WT, CCR2 KO, TNF KO, MyD88 KO or IFN-cR
KO mice by MACS purification on day 6 post infection. CD11c
+
and Ly6G
+ cells were first depleted via negative MACS selection.
CD11b
+Ly6C
+ monocytes were then isolated via positive CD11b
selection on magnetic separation columns according to the
manufacturer’s protocol (Miltenyi Biotec) resulting in purity
ranging from 90–95%. WT and CCR2 KO or MyD88 KO or
IFN-cR KO bone marrow cells were then fluorescently labeled
using respectively PKH26 (Sigma-Aldrich) and CellVue mem-
brane labeling kits (Polysciences) according to the manufacturer’s
protocol. Labeled cells were adoptively transferred at a 1-1 ratio
(total of 4610
6 cells/mouse) through tail vein injection in infected
recipient mice on day 6 post infection. Alternatively, CellVue
labeled WT or TNF KO monocytes from infected mice were
injected in CCR2 KO mice on day 6 post infection (8610
6 cells/
mouse). Twenty four hours after transfer the recipient mice were
sacrificed and presence of labeled cells was analyzed in the liver
non-parenchymal cell fraction.
Quantification of cytokines and NO2
Liver cells were resuspended at 2610
6/ml in RPMI 1640
(Gibco) supplemented with 10% FCS, 100 U/ml penicillin,
100 mg/ml streptomycin, 0.1 mM non-essential amino acids,
2 mM L-glutamine, and 5610
25 M 2-mercaptoethanol (all from
Invitrogen Life Technologies) and cultured in vitro (37uC).
Cytokines were quantified in culture supernatants collected after
2 days with specific sandwich ELISAs for IFN-c (PharMingen) or
TNF (R&D Systems), in accordance to the manufacturers’
protocols. NO2 quantification was assayed by a standard Griess
reaction as described [37].
FACS analysis
For surface markers, cells were stained for 30 min at 4uC using
conventional protocols. Cells were pre-incubated with anti-FccR
Ab (clone 2.4G2) before adding (1 mg/10
6 cells): FITC-conjugated
or APC-conjugated MHC-II (clone M5/114.15.2), PerCP-Cy5.5-
conjugated or PE-Cy7 conjugated CD11b (M1/70), FITC-
conjugated CD80 (16-10A1), FITC-conjugated CD86 (Gl-1),
FITC-conjugated Ly6C (AL-21), PE-conjugated or APC-conju-
gated CD11c (HL3), PE-conjugated CCR5 (C34-3448), unconju-
gated CCR2 (MC-21, a gift of Dr Matthias Mack, University of
Regensburg, Regensburg, Germany), FITC-conjugated CD74 (In-
1). Dead cells were excluded by 7-AAD staining. For intracellular
TNF staining, cells were cultured 6 hours in the presence of
brefeldin-A (BD Bioscience). For intracellular IFN-c staining, cells
were cultured 2 hours with anti-CD3 before adding brefeldin-A
(BD Bioscience). Four hours later, cells were fixed, permeabilised
(Fix/Perm kit, eBioscience) and analyzed. Antibodies used for
intracellular staining were APC-conjugated TNF (clone MP6-
XT22), unlabeled rabbit iNOS (M19) and APC-conjugated anti-
rabbit IgG. Cells were analyzed on a FACSCanto II and analysis
was performed using FlowJo. Antibodies were purchased from BD
Biosciences, eBioscience or R&D Systems.
Gene expression analysis
CD11b
+ Ly6C
+ cells were isolated from liver non-parenchymal
cells by negative selection for CD4, CD8 and CD19 followed by
positive Ly6C selection, using a two-step labeling with Ly6C-PE
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separation columns according to the manufacturer’s protocol
(Miltenyi Biotec) with a purity ranging from 90–95%. Three610
6
purified CD11b
+Ly6C
+ liver cells were put in Trizol (Invitrogen)
and stored at 280uC. For total liver extracts, pieces of liver
(0.560.5 cm) were minced, washed with HBSS and after
centrifugation put in Trizol. Gene expression in liver extracts or
isolated populations was analyzed by quantitative real time PCR
using the conditions described [43]. Results of the PCR analyses
were normalized against the house-keeping gene S12. Primers
used were: Cxcl-9 (Forward: TCCTTTTGGGCATCATCTTC,
Reverse: TTCCCCCTCTTTTGCTTTTT), Cxcl-10 (Forward:
GGATGGCTGTCCTAGCTCTG, Reverse: ATAACCCC-
TTGGGAAGATGG), Ccl3 (Forward: CGGAAGATTCCACGC-
CAATTC, Reverse: GGTGAGGAACGTGTCCTGAAG), Ccl4
(Forward: GCCCTCTCTCTCCTCTTGCT, Reverse: GTCT-
GCCTCTTTTGGTCAGG), Ccl5 (Forward: ACAGGTCAAAC-
TACAACTCCA, Reverse: TCAGCTCTTAGCAGACATTGG),
Ccl2 (Forward: CACTCACCTGCTGCTACTCATTCAC, Re-
verse: GGATTCACAGAGAGGGAAAAATGG), Mif (Forward:
CTTTTAGCGGCACGAACGAT, Reverse: AAGAACAGC-
GGTGCAGGTAA).
Microscopy, ALT and AST levels
Liver were fixed in Bouin solution (Sigma). Histological sections
embedded in paraffin were stained with Hematoxylin-eosin-
saffron for microscopic evaluations. Liver alanine aminotransfer-
ase (ALT) was measured in serum samples, using commercially
available kits (Boehringer Mannheim, Mannheim, Germany).
Statistical analysis
All comparisons were tested for statistical significance using the
unpaired t test with Welch’s correction from GraphPad Prism 4.0
software.
Acknowledgments
We thank Dr. Patrizia Loi and Dr. Ve ´ronique Flamand (Institut
d’Immunologie Me ´dicale, ULB, Belgium) for measuring ALT/AST levels;
Dr. M. Moser and Dr. C. Coquerelle (Institut de Biologie et Me ´decine
Mole ´culaires, ULB, Belgium) for preparing anti-IL-10R antibody; Dr R.
Bucala (Yale University School of Medicine, New Haven, CT, USA) for
providing Mif KO mice.
Author Contributions
Conceived and designed the experiments: TB AB. Performed the
experiments: TB MG BS YM MH. Analyzed the data: PDB AB.
Contributed reagents/materials/analysis tools: DE FT. Wrote the paper:
TB AB.
References
1. Sternberg JM (2004) Human African trypanosomiasis: clinical presentation and
immune response. Parasite Immunol 26: 469–476.
2. Naessens J (2006) Bovine trypanotolerance: A natural ability to prevent severe
anaemia and haemophagocytic syndrome? Int J Parasitol 36: 521–528.
3. Bosschaerts T, Guilliams M, Stijlemans B, De Baetselier P, Beschin A (2009)
Understanding the role of monocytic cells in liver inflammation using parasite
infection as a model. Immunobiology 214: 737–747.
4. Magez S, Radwanska M, Beschin A, Sekikawa K, De Baetselier P (1999) Tumor
necrosis factor alpha is a key mediator in the regulation of experimental
Trypanosoma brucei infections. Infect Immun 67: 3128–3132.
5. Drennan MB, Stijlemans B, Van den Abbeele J, Quesniaux VJ, Barkhuizen M,
et al. (2005) The induction of a type 1 immune response following a
Trypanosoma brucei infection is MyD88 dependent. J Immunol 175:
2501–2509.
6. Magez S, Radwanska M, Drennan M, Fick L, Baral TN, et al. (2006) Interferon-
gamma and nitric oxide in combination with antibodies are key protective host
immune factors during trypanosoma congolense Tc13 Infections. J Infect Dis
193: 1575–1583.
7. Shi M, Pan W, Tabel H (2003) Experimental African trypanosomiasis: IFN-
gamma mediates early mortality. Eur J Immunol 33: 108–118.
8. Guilliams M, Movahedi K, Bosschaerts T, VandenDriessche T, Chuah MK,
et al. (2009) IL-10 dampens TNF/inducible nitric oxide synthase-producing
dendritic cell-mediated pathogenicity during parasitic infection. J Immunol 182:
1107–1118.
9. Guilliams M, Oldenhove G, Noel W, Herin M, Brys L, et al. (2007) African
trypanosomiasis: naturally occurring regulatory T cells favor trypanotolerance
by limiting pathology associated with sustained type 1 inflammation. J Immunol
179: 2748–2757.
10. Guilliams M, Bosschaerts T, Herin M, Hunig T, Loi P, et al. (2008)
Experimental expansion of the regulatory T cell population increases resistance
to African trypanosomiasis. J Infect Dis 198: 781–791.
11. Bosschaerts T, Guilliams M, Noel W, Herin M, Burk RF, et al. (2008)
Alternatively activated myeloid cells limit pathogenicity associated with African
trypanosomiasis through the IL-10 inducible gene selenoprotein P. J Immunol
180: 6168–6175.
12. Serbina NV, Jia T, Hohl TM, Pamer EG (2008) Monocyte-mediated defense
against microbial pathogens. Annu Rev Immunol 26: 421–452.
13. Hertz CJ, Filutowicz H, Mansfield JM (1998) Resistance to the African
trypanosomes is IFN-gamma dependent. J Immunol 161: 6775–6783.
14. Blum J, Schmid C, Burri C (2006) Clinical aspects of 2541 patients with second
stage human African trypanosomiasis. Acta Trop 97: 55–64.
15. Hertz CJ, Mansfield JM (1999) IFN-gamma-dependent nitric oxide production
is not linked to resistance in experimental African trypanosomiasis. Cell
Immunol 192: 24–32.
16. Geissmann F, Jung S, Littman DR (2003) Blood monocytes consist of two
principal subsets with distinct migratory properties. Immunity 19: 71–82.
17. Serbina NV, Salazar-Mather TP, Biron CA, Kuziel WA, Pamer EG (2003)
TNF/iNOS-producing dendritic cells mediate innate immune defense against
bacterial infection. Immunity 19: 59–70.
18. Copin R, De Baetselier P, Carlier Y, Letesson JJ, Muraille E (2007) MyD88-
dependent activation of B220-CD11b+LY-6C+ dendritic cells during Brucella
melitensis infection. J Immunol 178: 5182–5191.
19. De Trez C, Magez S, Akira S, Ryffel B, Carlier Y, et al. (2009) iNOS-producing
inflammatory dendritic cells constitute the major infected cell type during the
chronic Leishmania major infection phase of C57BL/6 resistant mice. PLoS
Pathog 5: e1000494.
20. Aldridge JR, Jr., Moseley CE, Boltz DA, Negovetich NJ, Reynolds C, et al.
(2009) TNF/iNOS-producing dendritic cells are the necessary evil of lethal
influenza virus infection. Proc Natl Acad Sci U S A 106: 5306–5311.
21. Tokuyama H, Ueha S, Kurachi M, Matsushima K, Moriyasu F, et al. (2005)
The simultaneous blockade of chemokine receptors CCR2, CCR5 and CXCR3
by a non-peptide chemokine receptor antagonist protects mice from dextran
sodium sulfate-mediated colitis. Int Immunol 17: 1023–1034.
22. Serbina NV, Pamer EG (2006) Monocyte emigration from bone marrow during
bacterial infection requires signals mediated by chemokine receptor CCR2. Nat
Immunol 7: 311–317.
23. Tacke F, Alvarez D, Kaplan TJ, Jakubzick C, Spanbroek R, et al. (2007)
Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to
accumulate within atherosclerotic plaques. J Clin Invest 117: 185–194.
24. Schober A, Bernhagen J, Weber C (2008) Chemokine-like functions of MIF in
atherosclerosis. J Mol Med 86: 761–770.
25. Paiva CN, Figueiredo RT, Kroll-Palhares K, Silva AA, Silverio JC, et al. (2009)
CCL2/MCP-1 controls parasite burden, cell infiltration, and mononuclear
activation during acute Trypanosoma cruzi infection. J Leukoc Biol.
26. Engel D, Dobrindt U, Tittel A, Peters P, Maurer J, et al. (2006) Tumor necrosis
factor alpha- and inducible nitric oxide synthase-producing dendritic cells are
rapidly recruited to the bladder in urinary tract infection but are dispensable for
bacterial clearance. Infect Immun 74: 6100–6107.
27. Fogg DK, Sibon C, Miled C, Jung S, Aucouturier P, et al. (2006) A clonogenic
bone marrow progenitor specific for macrophages and dendritic cells. Science
311: 83–87.
28. Varol C, Landsman L, Fogg DK, Greenshtein L, Gildor B, et al. (2007)
Monocytes give rise to mucosal, but not splenic, conventional dendritic cells.
J Exp Med 204: 171–180.
29. Serbina NV, Kuziel W, Flavell R, Akira S, Rollins B, et al. (2003) Sequential
MyD88-independent and -dependent activation of innate immune responses to
intracellular bacterial infection. Immunity 19: 891–901.
30. Leppert BJ, Mansfield JM, Paulnock DM (2007) The soluble variant surface
glycoprotein of African trypanosomes is recognized by a macrophage scavenger
receptor and induces I kappa B alpha degradation independently of TRAF6-
mediated TLR signaling. J Immunol 179: 548–556.
Regulation of TIP-DC Development
PLoS Pathogens | www.plospathogens.org 11 August 2010 | Volume 6 | Issue 8 | e100104531. Ngure RM, Eckersall P, Burke J, Karori SM, Mwangi WW, et al. (2009)
Endotoxin-like effects in acute phase response to Trypanosoma brucei brucei
infection are not due to gastrointestinal leakage. Parasitol Int 58: 325–329.
32. Pentreath VW (1994) Endotoxins and their significance for murine trypanoso-
miasis. Parasitol Today 10: 226–229.
33. Dagenais TR, Freeman BE, Demick KP, Paulnock DM, Mansfield JM (2009)
Processing and presentation of variant surface glycoprotein molecules to T cells
in African trypanosomiasis. J Immunol 183: 3344–3355.
34. Geissmann F, Auffray C, Palframan R, Wirrig C, Ciocca A, et al. (2008) Blood
monocytes: distinct subsets, how they relate to dendritic cells, and their possible
roles in the regulation of T-cell responses. Immunol Cell Biol 86: 398–408.
35. Shi M, Wei G, Pan W, Tabel H (2006) Experimental African trypanosomiasis: a
subset of pathogenic, IFN-gamma-producing, MHC class II-restricted CD4+ T
cells mediates early mortality in highly susceptible mice. J Immunol 176:
1724–1732.
36. Dempsey WL, Mansfield JM (1983) Lymphocyte function in experimental
African trypanosomiasis. V. Role of antibody and the mononuclear phagocyte
system in variant-specific immunity. J Immunol 130: 405–411.
37. Namangala B, Noel W, De Baetselier P, Brys L, Beschin A (2001) Relative
contribution of interferon-gamma and interleukin-10 to resistance to murine
African trypanosomosis. J Infect Dis 183: 1794–1800.
38. Bourdi M, Masubuchi Y, Reilly TP, Amouzadeh HR, Martin JL, et al. (2002)
Protection against acetaminophen-induced liver injury and lethality by
interleukin 10: role of inducible nitric oxide synthase. Hepatology 35: 289–298.
39. Devey L, Ferenbach D, Mohr E, Sangster K, Bellamy CO, et al. (2009) Tissue-
resident macrophages protect the liver from ischemia reperfusion injury via a
heme oxygenase-1-dependent mechanism. Mol Ther 17: 65–72.
40. Louis H, Le Moine O, Goldman M, Deviere J (2003) Modulation of liver injury
by interleukin-10. Acta Gastroenterol Belg 66: 7–14.
41. Holt MP, Cheng L, Ju C (2008) Identification and characterization of infiltrating
macrophages in acetaminophen-induced liver injury. J Leukoc Biol 84:
1410–1421.
42. Karlmark KR, Weiskirchen R, Zimmermann HW, Gassler N, Ginhoux F, et al.
(2009) Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon
liver injury promotes hepatic fibrosis. Hepatology 50: 261–274.
43. Ghassabeh GH, De Baetselier P, Brys L, Noel W, Van Ginderachter JA, et al.
(2006) Identification of a common gene signature for type II cytokine-associated
myeloid cells elicited in vivo in different pathologic conditions. Blood 108:
575–583.
Regulation of TIP-DC Development
PLoS Pathogens | www.plospathogens.org 12 August 2010 | Volume 6 | Issue 8 | e1001045